Kaleido Biosciences, Inc.

Flagship Pioneering, the biopharma start-up creation firm behind Moderna , is broadening its horizon beyond its base in Cambridge, MA. It unveiled a new alliance with the UK government in London on 2

Jason Gardner is just a month into his role as CEO of Ampersand Biomedicines , one of the latest companies to emerge from Flagship Pioneering , but is nevertheless confident it can deliver a “new pa

Clovis Oncology has warned it is “increasingly probable” that it will enter bankruptcy as revenues shrink and the regulatory outlook worsens for its only marketed drug, Rubraca. The Bolder, CO-based

Biotech entrepreneur Geoffrey von Maltzahn believes his company, Tessera Therapeutics , has a gene editing technology more powerful than CRISPR-Cas9, and after years of secretive lab development, is